搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Psychology Today
9 小时
The Death of Dieting
Dieting for weight loss has long survived scientific criticism. But GLP-1 medicines may be the final nail in the coffin of ...
5 天
Ask the Expert: Bariatric surgery improving outcomes for people suffering from obesity
Eating healthy and exercising are important to maintaining a healthy lifestyle, but for some people - it's not enough.
2 天
Plastic Surgeons Predict The Top Aesthetic Procedures For 2025
Experts predict 2025's top plastic surgery itrends, from blepharoplasties, facelifts, and post weight-loss body procedures, ...
1 天
Weight Loss Drug Zepbound Could Treat Sleep Apnea Without a CPAP or Surgery
GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...
CNN
9 天
‘Lifting from head to toe’: Weight-loss drugs boost popularity of surgeries to remove ...
In 2022, the year after the first GLP-1 medication for weight loss, Wegovy, was approved in the US, breast lifts and tummy ...
2 天
on MSN
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Rolling Out
10 天
Bariatric surgery’s surprising impact on your skin and hair
Discover the unexpected ways bariatric surgery could transform your skin and hair—what’s really happening beneath the surface ...
NOLA.com
11 天
Ochsner leads Louisiana in bariatric surgery with cutting-edge care and comprehensive ...
Ochsner Lafayette General has become a regional leader in bariatric surgery by using the latest technology, focusing on a ...
10 天
Ozempic Not Working for You? A Stomach Balloon Is the Latest Hope for Weight Loss
MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.
Medscape
13 天
Bariatric Surgery Demand Declines in the Era of GLP-1 RAs
A cross-sectional study of privately insured patients with obesity showed that the use of GLP-1 RAs soared from 2022 to 2023, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈